About Us

IOVaxis Therapeutics is a spin-off of ImmuOn Thereapeutics founded by industrial veterans from major MNC. IOVaxis is the leading Chinese domestic company that works at cancer therapeutic vaccines, including personal therapeutic cancer and vaccines with shared neoantigens or targeted vaccines. The company is located in Nantong City, Jiangsu Province, China. It has build a 1200 m2 research lab including a 300 m2 GLP workshop. Over the past few years, the company has collaborated with leading companies in the field, such as BGI, Wuxi Decode, CPC, Qiagen and Yuce for cancer vaccine design and development. Currently, IOvaxis has two IND application for its IOV03 and IOV04 being reviewed by NMPA. More

Projects

More